Bioton SA logo

BIO - Bioton SA Share Price

PLN5 -0.2  -3.3%

Last Trade - 04/03/21

Small Cap
Market Cap £81.1m
Enterprise Value £100.1m
Revenue £34.9m
Position in Universe 198th / 791
Unlock BIO Revenue
Relative Strength (%)
1m +13.4%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -36.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
377.3 332.6 277.6 361.6 241.2 202 -11.7%
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 September 2020, BIOTONSA revenues decreased 12% to PLN130.7M. Net income totaledPLN15.2M vs. loss of PLN87.6M. Revenues reflect Malta(Country) segment decrease of 83% to PLN947K, Other Foreignsegment decrease of 98% to PLN22K. Net Income reflectsInsulin (Bioton SA) segment income totaling PLN25.7M vs.loss of PLN1.6M. Basic Earnings per Share excludingExtraordinary Items increased from -PLN1.02 to PLN0.18.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


BIO Revenue Unlock BIO Revenue

Net Income

BIO Net Income Unlock BIO Revenue

Normalised EPS

BIO Normalised EPS Unlock BIO Revenue

PE Ratio Range

BIO PE Ratio Range Unlock BIO Revenue

Dividend Yield Range

BIO Dividend Yield Range Unlock BIO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BIO EPS Forecasts Unlock BIO Revenue
Profile Summary

Bioton SA is a Poland-based company active in the pharmaceutical sector. The Company is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The Company's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.

Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated August 2, 2004
Public Since March 16, 2005
No. of Shareholders: n/a
No. of Employees: 527
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Warsaw Stock Exchange
Shares in Issue 85,864,200
Free Float (0.0%)
Eligible for
BIO Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BIO
Upcoming Events for BIO
Frequently Asked Questions for Bioton SA
What is the Bioton SA share price?

As of 04/03/21, shares in Bioton SA are trading at PLN5, giving the company a market capitalisation of £81.1m. This share price information is delayed by 15 minutes.

How has the Bioton SA share price performed this year?

Shares in Bioton SA are currently trading at PLN5 and the price has moved by 61.81% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioton SA price has moved by 51.31% over the past year.

What are the analyst and broker recommendations for Bioton SA?

Of the analysts with advisory recommendations for Bioton SA, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Bioton SA is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Bioton SA next release its financial results?

Bioton SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Bioton SA dividend yield?

Bioton SA does not currently pay a dividend.

Does Bioton SA pay a dividend?

Bioton SA does not currently pay a dividend.

When does Bioton SA next pay dividends?

Bioton SA does not currently pay a dividend.

How do I buy Bioton SA shares?

To buy shares in Bioton SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Bioton SA?

Shares in Bioton SA are currently trading at PLN5, giving the company a market capitalisation of £81.1m.

Where are Bioton SA shares listed? Where are Bioton SA shares listed?

Here are the trading details for Bioton SA:

Country of listing: Poland
Exchange: WSE
Ticker Symbol: BIO
What kind of share is Bioton SA?

Based on an overall assessment of its quality, value and momentum, Bioton SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Bioton SA share price forecast 2021?

We were not able to load any forecast data for Bioton SA.

How can I tell whether the Bioton SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioton SA. Over the past six months, the relative strength of its shares against the market has been -3.45%. At the current price of PLN5, shares in Bioton SA are trading at 9.74% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Bioton SA PE Ratio?

We were not able to find PE ratio data for Bioton SA.

Who are the key directors of Bioton SA?

Bioton SA's management team is headed by:

Adam Polonek - MGB
Dariusz Trzeciak - VSU
Jubo Liu - CSU
Vaidyanathan Viswanath - VSU
Ramesh Rajentheran - SUB
Hao Fan - SUB
Nicola Cadei - SUB
Wei Ming Tan - SUB
Jeremy Launders - CMG
Who are the major shareholders of Bioton SA?

Here are the top five shareholders of Bioton SA based on the size of their shareholding:

Yifan Pharmaceutical Co Ltd Corporation
Percentage owned: 31.72% (27.2m shares)
Troqueera Enterprises, Ltd. Corporation
Percentage owned: 9.88% (8.48m shares)
Basolma Holding Ltd Corporation
Percentage owned: 7.16% (6.15m shares)
Ais Investment 2 Sp. z.o.o. Corporation
Percentage owned: 6% (5.15m shares)
Cui (Wenjun) Individual Investor
Percentage owned: 5% (4.29m shares)
Similar to BIO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.